You searched for "gases"
IN FOCUS - Beyond 2020: what next for global eye health?
The year 2020 is a pivotal year for global eye health. It marks the conclusion of ‘VISION 2020: The Right to Sight’ which has guided action for the past two decades, and the end of the World Health Organization (WHO)...Highlights from The RCOphth Annual Congress 2023
Check in here for live updates and media from the RCOphth Annual Congress 2023 being held in Birmingham's ICC between 22-25 May.Welcome from Guest Editor Evelyn Mensah
I loved attending RCOphth Annual Congress face-to-face in Glasgow this year. How wonderful it was to see old friends and meet new after two pandemic years. At Congress I chaired the session on ‘Racism in the NHS’ with ‘three professors’...The PMFA Journal - December/January 2019 issue available
FEATURES IN THIS ISSUE: Life after medicine by Andrew Burd. / The creation of PlayDoh® models as an educational tool for teaching anatomy of the eyelid by Maria De Bono Agius, Roth M Manners, Fiona R Jazayeri, Christina V Miller and Sally M Webber. AND MUCH MORE...The PMFA Journal - April/May 2019 issue available
FEATURES IN THIS ISSUE: Genioplasty by Natasha Berridge and Paul Johnson. / Immediate versus delayed post mastectomy breast reconstruction by Diaa Othman, Adil Khan and Mumahhad Riaz. / Laser tattoo removal by Dana Alessa and Eric F Bernstein. AND MUCH MORE...Managing cataract surgery in a patient with diabetic maculopathy
A 56-year-old type 2 diabetic with previously treated bilateral diabetic maculopathy develops a cataract requiring surgery in the right eye. He has had grid laser previously, followed intermittently by intravitreal triamcinalone, Avastin and more recently Lucentis in both eyes. His...
Multimodal Retinal Imaging
Understanding of rapidly advancing retinal imaging techniques is important as they have changed the management of retinal conditions considerably. Interpretation of these tests is a vital skill in the armamentarium of every practising ophthalmologist. The book is directed at general...
ROP ocular outcomes after Bevacizumab treatment
The relationship between refractive outcomes and biometric parameters were evaluated following intravitreal Bevacizumab (IVB) monotherapy. Sixty-three infants were grouped into 1) infants treated with VB monotherapy for ROP (six with zone 1 and eight with posterior zone II retinopathy of...
Aflibercept, bevacizumab or ranibizumab for DMO
This is a two-year randomised clinical trial of 660 patients with visual acuity impairment from diabetic macular oedema (DMO) who were randomised to monthly injections of 2.0mg aflibercept, 1.25 mg bevacizumab or 0.3mg ranibizumab. Focal or grid laser was performed...
Update on primary angle closure glaucoma
This review article considers primary angle-closure glaucoma which is responsible for half of glaucoma-related blindness worldwide. Angle closure is characterised by appositional contact between the iris and trabecular meshwork. It tends to develop in eyes with shallow anterior chambers, anteriorly...
Aflibercept for the treatment of neovascular glaucoma
The aim of this study was to investigate initial results regarding the treatment of neovascular glaucoma (NVG) with intravitreal aflibercept. NVG is classified into stages 0-3. In stages 1 and 2, abnormal vessel proliferation is seen with or without elevated...
